XML 61 R22.htm IDEA: XBRL DOCUMENT v3.24.3
Business Segments
6 Months Ended
Sep. 30, 2024
Segment Reporting [Abstract]  
Business Segments Business Segments
Our current reportable segments consist of (i) North American OTC Healthcare and (ii) International OTC Healthcare. We evaluate the performance of our operating segments and allocate resources to these segments based primarily on contribution margin, which we define as gross profit less advertising and marketing expenses.
The tables below summarize information about our reportable segments.
 Three Months Ended September 30, 2024
(In thousands)North American OTC
Healthcare
International OTC
Healthcare
Consolidated
Total segment revenues*$239,811 $43,974 $283,785 
Cost of sales107,782 18,621 126,403 
Gross profit132,029 25,353 157,382 
Advertising and marketing34,889 6,520 41,409 
Contribution margin$97,140 $18,833 $115,973 
Other operating expenses 31,634 
Operating income $84,339 
* Intersegment revenues of $0.9 million were eliminated from the North American OTC Healthcare segment.

 Six Months Ended September 30, 2024
(In thousands)North American OTC
Healthcare
International OTC
Healthcare
Consolidated
Total segment revenues*472,127 $78,800 $550,927 
Cost of sales213,341 34,182 247,523 
Gross profit258,786 44,618 303,404 
Advertising and marketing68,642 12,132 80,774 
Contribution margin$190,144 $32,486 $222,630 
Other operating expenses 66,245 
Operating income $156,385 
* Intersegment revenues of $1.6 million were eliminated from the North American OTC Healthcare segment.

 Three Months Ended September 30, 2023
(In thousands)North American OTC
Healthcare
International OTC
Healthcare
Consolidated
Total segment revenues*$244,423 $41,893 $286,316 
Cost of sales107,466 18,830 126,296 
Gross profit 136,957 23,063 160,020 
Advertising and marketing35,389 4,713 40,102 
Contribution margin$101,568 $18,350 $119,918 
Other operating expenses 31,668 
Operating income $88,250 
* Intersegment revenues of $0.6 million were eliminated from the North American OTC Healthcare segment.
 Six Months Ended September 30, 2023
(In thousands)North American OTC
Healthcare
International OTC
Healthcare
Consolidated
Total segment revenues*$490,566 $75,059 $565,625 
Cost of sales217,542 33,390 250,932 
Gross profit 273,024 41,669 314,693 
Advertising and marketing66,790 9,543 76,333 
Contribution margin$206,234 $32,126 $238,360 
Other operating expenses 64,916 
Operating income $173,444 
* Intersegment revenues of $2.0 million were eliminated from the North American OTC Healthcare segment.


The tables below summarize information about our segment revenues from similar product groups.
Three Months Ended September 30, 2024
(In thousands)North American OTC
Healthcare
International OTC
Healthcare
Consolidated
Analgesics$27,147 $1,075 $28,222 
Cough & Cold23,054 6,221 29,275 
Women's Health54,309 6,038 60,347 
Gastrointestinal41,911 18,150 60,061 
Eye & Ear Care36,140 6,646 42,786 
Dermatologicals33,640 2,215 35,855 
Oral Care20,698 3,385 24,083 
Other OTC2,912 244 3,156 
Total segment revenues$239,811 $43,974 $283,785 
Six Months Ended September 30, 2024
(In thousands)North American OTC
Healthcare
International OTC
Healthcare
Consolidated
Analgesics$54,158 $2,357 $56,515 
Cough & Cold38,015 11,957 49,972 
Women's Health104,804 10,121 114,925 
Gastrointestinal86,198 31,878 118,076 
Eye & Ear Care79,459 11,457 90,916 
Dermatologicals65,243 3,967 69,210 
Oral Care38,372 6,485 44,857 
Other OTC5,878 578 6,456 
Total segment revenues$472,127 $78,800 $550,927 
Three Months Ended September 30, 2023
(In thousands)North American OTC
Healthcare
International OTC
Healthcare
Consolidated
Analgesics$29,976 $1,386 $31,362 
Cough & Cold25,970 7,263 33,233 
Women's Health55,000 7,072 62,072 
Gastrointestinal38,703 14,061 52,764 
Eye & Ear Care39,745 7,125 46,870 
Dermatologicals33,018 1,469 34,487 
Oral Care19,312 3,469 22,781 
Other OTC2,699 48 2,747 
Total segment revenues$244,423 $41,893 $286,316 
Six Months Ended September 30, 2023
(In thousands)North American OTC
Healthcare
International OTC
Healthcare
Consolidated
Analgesics$57,158 $2,228 $59,386 
Cough & Cold46,344 13,315 59,659 
Women's Health109,955 12,028 121,983 
Gastrointestinal83,384 26,971 110,355 
Eye & Ear Care79,216 11,146 90,362 
Dermatologicals67,696 2,807 70,503 
Oral Care41,038 6,491 47,529 
Other OTC5,775 73 5,848 
Total segment revenues$490,566 $75,059 $565,625